Compassion Response Network decided in September 2003, to conduct a trial in Kinshasa of Imusil treatment on three advanced HIV/AIDS patients, with comprehensive blood testing and medical checks extending over six months after the treatment was provided.
For each patient, the treatment consisted of a single injection of Imusil. This is unusual, because most other treatments for HIV/AIDS rely upon daily or regular treatment.
Of the three patients selected, one was rejected from the trial because the bDNA blood test did not indicate HIV infection. We have a third sample of Imusil still in Kinshasa ... Read even more
